DoenickeABrandJPerrinVL. Possible benefit of GR43175, a novel 5HT1-like receptor agonist, for the acute treatment of severe migraine. Lancet1988; 1: 1309–11.
2.
Tfelt-HansenP.Early clinical experience with subcutaneous GR43175 in acute migraine. Cephalalgia (1989) 9 (Suppl. 9) (in press).